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Background: Rapid detection and therapeutic intervention for infectious and emerging diseases is a major scientific
goal in biodefense and public health. Toward this end, cytokine profiles in human blood were investigated using a
human whole blood ex vivo exposure model, called WEEM.
Results: Samples of whole blood from healthy volunteers were incubated with seven pathogens including Yersinia
pseudotuberculosis, Yersinia enterocolitica, Bacillus anthracis, and multiple strains of Yersinia pestis, and multiplexed
protein expression profiling was conducted on supernatants of these cultures with an antibody array to detect 30
cytokines simultaneously. Levels of 8 cytokines, IL-1α, IL-1β, IL-6, IL-8, IL-10, IP-10, MCP-1 and TNFα, were significantly
up-regulated in plasma after bacterial exposures of 4 hours. Statistical clustering was applied to group the
pathogens based on the host response protein expression profiles. The nearest phylogenetic neighbors clustered
more closely than the more distant pathogens, and all seven pathogens were clearly differentiated from the
unexposed control. In addition, the Y. pestis and Yersinia near neighbors were differentiated from the B. anthracis
strains.
Conclusions: Cluster analysis, based on host response cytokine profiles, indicates that distinct patterns of
immunomodulatory proteins are induced by the different pathogen exposures and these patterns may enable
further development into biomarkers for diagnosing pathogen exposure.Background
Yersinia pestis and Bacillus anthracis are two pathogens
of significant concern to public health from a biodefense
perspective [1,2]. Y. pestis, the causative agent of plague, is
a Gram-negative, highly communicable coccobacillus that
has been responsible for three historic pandemics with
high mortality rates [3-5]. The microorganism possesses a
Type III secretion mechanism common to several human,
animal and plant pathogens, whereby a series of pathogen-
specific structural proteins form a syringe-like structure
capable of injecting virulence factors into the mammalian
host cell. These virulence factors then facilitate pathogen
use of host nutrients and thwart the host immune response,* Correspondence: brett.chromy@ucdmc.ucdavis.edu
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reproduction in any medium, provided the orultimately causing cell and host death [6,7]. Naturally occur-
ring plague can be transmitted from infected fleas and
rodents to humans, and although the pathogen can be pha-
gocytosed, it can also resist destruction by manipulating the
host defense mechanism(s), potentially through antigenic
mimicry [8]. Y. pestis then multiplies rapidly leading to ne-
crosis of lymph nodes, a condition known as bubonic
plague, which can result in death if untreated [2]. In some
cases the infection can spread through the blood stream
resulting in systemic plague (septicemia) or to the lungs
resulting in the highly contagious and deadly form of the
disease known as pneumonic plague. There are currently
no rapid, widely available diagnostic tests for plague, and
the most common treatment is streptomycin [2,3], an anti-
biotic with adverse effects.
Two other species from the genus Yersinia are also
human pathogens: Y. pseudotuberculosis and Y.
enterocolitica [9,10]. Despite their high degree of se-
quence similarity to Y. pestis, these two near neighborsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ging from abdominal pain to septicemia in humans,
usually caused by infection through contaminated
food. Infections caused by Y. pseudotuberculosis or Y.
enterocolitica can be effectively treated with antibiotics
and in most cases are self-limiting. Notably, Y. pestis is
reported to have evolved from Y. pseudotuberculosis
within the past 10,000 years [11].
B. anthracis is a Gram-positive, rod-shaped spore-
forming bacterial pathogen and the causative agent of
anthrax [12,13]. Human, livestock, and wildlife mortal-
ities attributable to anthrax occur in numerous regions
of the world, although the majority of cases are found
in less industrialized nations [14]. Three forms of the
disease have been described: cutaneous, intestinal and
inhalational. While cutaneous and intestinal forms may
be less severe, inhalational anthrax is often fatal without
prompt antibiotic treatment [13]. The primary mechan-
isms of virulence employed by B. anthracis are asso-
ciated with two virulence plasmids designated pXO1
and pXO2 [15]. The net effect of these plasmids is vir-
tually unhindered proliferation of B. anthracis within
the host, hemorrhaging, cardio-pulmonary collapse, and
death.
The regulation of production of host cytokines by both
Yersinia and B. anthracis has been described previously.
Pickering A. K. et. al. measured cytokine levels in human
dendritic cell supernatant and in mouse peritoneal
macrophages exposed to B. anthracis spores [16]. They
observed significant increase in TNF-α, IL-6, IL-1β, IL-8,
and IL-12 in human dendritic cell supernatants by 5
hours post-exposure. High levels of IL-6, and TNF-α
were observed in the supernatant from B. anthracis
infected mouse peritoneal macrophages [16]. In a mouse
model, 6 cytokines, namely IL-12p70, TNF, IFN-γ, MCP-1,
IL-10, and IL-6, were increased significantly in mouse lung
at 48 hours of Y. pestis infection [17]. In previous work
comparing exposures to different bacterial pathogens,
distinct patterns of cytokine expression levels were found
that could discriminate the particular host response [18],
including while using pathogen-specific LPS in whole
blood [19].
The hypothesis for the present study is that ex-
posure to diverse bacterial pathogen strains would
result in distinct cytokine profiles in the host, with
strains from the same species exhibiting more simi-
lar profiles than strains from phylogenetically dis-
tant species. A multiplex cytokine protein chip was
used, and a multivariate approach was taken that
combined expression data on multiple cytokines.
Multivariate clustering techniques were used to es-
tablish cytokine expression profiles after ex vivo ex-
posure of whole blood to seven pathogens.Methods
Bacterial strains and culture conditions
The bacterial strains used in this study include: B.
anthracis Ames (virulent), B. anthracis Sterne (vaccine
strain), Y. pestis KIM5 D27 (attenuated, pgm-). Y. pestis
India/P (attenuated, pgm-), and Y. pestis NYC (virulent),
Y. pseudotuberculosis serotype 1 PB1, and Y. enterocoli-
tica WA serovar 0:8. Bacteria were grown on tryptose
blood agar slants at 26°C for 1-2 days and subsequently
collected using 2 ml of 0.033M potassium-phosphate,
pH 7.0;.bacterial densities were measured at OD620
(1 OD620 = 1.2 x 10
9 colony forming units/ml).
Whole blood ex vivo exposure model (WEEM)
Human blood was collected from a healthy donor by
venipuncture using CPT Vacutainer tubes (Becton Dick-
inson) containing citrate. Informed consent was obtained
and our blood collection protocol was approved by the
LLNL IRB committee. Separate CPT tubes were used for
the unexposed control and 7 different bacterial expo-
sures (B. anthracis Ames, B. anthracis Sterne, Y. pestis
NYC, Y. pestis India/P, Y. pestis KIM5 D27, Y. pseudotu-
berculosis, and Y. enterocolitica). Bacteria were added to
blood within 15 minutes of collection at a multiplicity of
infection ratio of 5:1. This ratio was determined against
white blood cells in whole blood:7 x 106 cells/ml. Each
whole blood sample was incubated with bacteria for 4
hours at 37°C in 5% CO2 Following incubation, plasma
was collected by centrifugation at 2000 x g for 10 min at
4°C. The control plasma was obtained in the same way
and treated with 0.033 M potassium-phosphate as a
mock exposure. These plasma samples were used for
cytokine measurements.
Cytokine immunoassays with protein arrays
The measurements of cytokines were performed using
Zyomyx Protein Profiling Biochips (Hayward, CA). These
protein arrays allow the simultaneous quantification of
30 biologically relevant cytokines, as determined by Zyo-
myx, Inc: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7,
IL-8, IL-10, IL-12(p40), IL-12(p40/p70), IL-12(p70), IL-
13, IL-15, TNFα, TNFβ, Eotaxin, MCP-1, MCP-3,
TRAIL, CD95(sFas), MIG, sICAM-1, IP-10, CD23, TGF-
β, GM-CSF, GCSF, IFN-γ. Each cytokine assay was opti-
mized for the Zyomyx Protein Profiling Biochip based on
many factors including the availability of antibodies and
the sensitivity and specificity of antibody-cytokine inter-
actions. Each protein array chip is designed with 6 inde-
pendent microfluidic channels that allow up to 6
samples to be loaded into isolated regions of an array.
Antibodies specific for 30 analytes were arrayed in each
channel, and each antibody was arrayed in redundancy
on 5 pillars within the channel. Accordingly, a cytokine
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All immunoassay steps, including sample loading, wash-
ing, and detection, were performed with a fully auto-
mated biochip processing station (Zyomyx Assay 1200
workstation). Eight protein array chips were used in
these experiments. Two chips were used for generating
calibration curves with a calibration standard kit con-
taining 30 analytes (Zyomyx, Inc.). Sample (40 μl) was
injected into each channel of the protein array chips.
Standard solutions were applied to two channels of each
chip for chip-to-chip normalization. Triplicates of con-
trol and pathogen-exposed plasmas were applied ran-
domly to four channels of 6 protein array chips. Protein
arrays were scanned at 532 nm with Zyomyx Scanner
100 after immunoassays. Zyomyx Data Reduction soft-
ware was used for normalization, calculation of calibra-
tion curves. Dixon’s test was used to remove outliers,
and the median feature intensity was background sub-
tracted. Concentrations of cytokines in plasma samples
were determined by a four parameter logistic model.
Cluster analysis of cytokine data
Multiple hierarchical clustering methods were used to
group the pathogen exposures based on the multivariate
cytokine expression profiles induced in a host infection
model system. First, hierarchical agglomerative clustering
[20] was applied to group the control and the seven
pathogen-exposed samples based on their cytokine con-
centration profiles. Each of the eight samples was charac-
terized by the multivariate vector of its average log10
concentration over the cytokines. The samples were then
clustered based on the following distance measures be-
tween the samples and between the clusters.
Distance between two samples was defined using two
distance metrics:
 Euclidean distance
 Correlation distance: (1 – Spearman correlation
coefficient between the samples)
Distance between two clusters was defined using three
methods:
 Complete linkage (furthest neighbor): the largest
distance between members of the clusters
 Single linkage (nearest neighbor): the smallest
distance between members of the clusters
 Average linkage (group average): the average
distance between members of the clusters
Given a pair of distance metrics between samples and
clusters, the algorithm was initialized with the eight sam-
ples forming eight different clusters and then processediteratively by joining the two most similar clusters. The
tree was built starting from the individual samples, using
an agglomerative (bottom up) approach. The resulting
hierarchy of clusters was displayed as a dendrogram.
These traditional clustering methods provide a quick, ex-
ploratory overview of the data. However, these methods do
not estimate the optimal number of clusters in the data; ra-
ther, the clustering is performed exhaustively from the low-
est possible level of the hierarchy where each sample forms
its own cluster, to the highest level where all samples are
grouped into one cluster.
In addition to the traditional hierarchical agglomera-
tive clustering method, the hierarchical ordered parti-
tioning and collapsing hybrid (HOPACH) algorithm was
also applied to the cytokine measurements [21]. In con-
trast with the previous approaches where the tree was
built starting from the individual samples as the leaf
nodes, HOPACH used a hybrid divisive-agglomerative
approach: it started from the root cluster containing all
the samples (divisive, top down approach), then divided
the root down to leaf nodes, with an extra collapsing (ag-
glomerative) step after each iteration that combined simi-
lar clusters. Based on the correlation distance between
samples, HOPACH determined the split that minimized a
measure of cluster homogeneity called the median split sil-
houette. While computationally more expensive than the
previous methods, HOPACH was expected to perform bet-
ter because of its dynamic approach to update and poten-
tially revise the clusters at every step of the iteration.
Furthermore, HOPACH also estimated the optimal num-
ber of clusters from the data, and thus offered another ad-
vantage over the previous methods.
Computations were performed in the R computing en-
vironment (http://www.r-project.org/) and the HOPACH
package [21].
Results
Cytokine levels were examined using an ex vivo model,
termed WEEM for whole blood ex vivo exposure model.
Individual samples of anti-coagulated human blood were
incubated with B. anthracis Ames, B. anthracis Sterne, Y.
pestis KIM5 D27, Y. pestis NYC, Y. pestis India/P, Y.
enterocolitica, and Y. pseudotuberculosis. After 4 hours
exposure, blood cells were removed by low-speed centri-
fugation and concentrations of 30 cytokines in the
plasma were measured with protein arrays. Concentra-
tions of fourteen cytokines, GCSF, IFNγ, GM-CSF, IL-7,
IL-12(p70), IL-12(p40/p70), IL-13, IL-2, IL-3, IL-4, IL-5,
MCP-3, TGFβ, and TNFβ were below the limit of detec-
tion in this study. The following 16 cytokines were
detected: Eotaxin, IL-10, IL-12(p40), IL-15, IL-1α, IL-1β,
IL-6, IL-8, IP-10, MCP-1, MIG, TNFα, TRAIL, sCD23,
sCD95, and sICAM-1 (Figure 1). To determine if there
were significant differences among the levels of cytokines
Figure 1 Scatter plots of 16 cytokine concentrations detected in human blood following ex vivo bacterial exposures. Cytokine
concentrations were displayed on a logarithmic scale. The cytokines shown here were detected out of the 30 cytokines in the arrays. The 8
cytokines that were found to be statistically differentially expressed among these samples are highlighted with rectangular boxes. Each mark
delineates the average of triplicate exposure samples. Each exposure sample is loaded onto a protein array chip that contains 5 independent
measurements per cytokine meaning that fifteen measurements are used to obtain these data.
Chromy et al. BMC Microbiology 2012, 12:79 Page 4 of 9
http://www.biomedcentral.com/1471-2180/12/79in the control and pathogen exposed plasma samples, F-
tests were performed. For thirteen of these 16 cytokines,
all three replicates were detected and these cytokines
were subjected to F-tests. Statistical analysis indicated
that 8 cytokines (IL-1α, IL-1β, IL-6, IL-8, IL-10, IP-10,
MCP-1, and TNFα) had differentially elevated expression
profiles following different bacterial exposures. Figure 2
shows the concentrations (pg/ml) of these cytokines in
the control and bacteria exposed plasma samples. The F-
tests revealed that the other five cytokines containing
complete datasets, TRAIL, sCD23, sCD95, MIG, and
sICAM-1, had no significant difference between bacterial
exposures and the mock-exposed control. Moreover,
there was a great variation in absolute concentrations be-
tween cytokines. For example, the concentrations of
TNFα, sCD23, and sICAM-1 were as high as 1 x 104
-105 pg/ml, whereas IL-10 was much lower, about 16 pg/
ml.
Marked differences in induced cytokine patterns be-
tween B. anthracis and Yersinia exposures were found.
Also, the levels of induction of these cytokines differed
among the different bacteria. For example, Yersinia spe-
cies induced much higher cytokine response than B.
anthracis for IL-1α, IL-1β, IL-6, and TNF-α (Figure 2).
The two strains of B. anthracis bacteria induced different
levels of IL-1β and TNF-α (Figure 2), including 2.2 times
higher concentration of IL-1β and 1.6 times higher con-
centration of TNF-α for the Sterne strain than the Ames
strain of B. anthracis. These differences were statistically
significant (pairwise t-test p value = 0.0039 for IL-1β and
0.022 for TNF-α). To discriminate Y. pestis exposurefrom near neighbors, IL-10 levels can be used, showing
cytokine concentrations following Y. enterocolitica ex-
posure and Y. pseudotuberculosis exposure that are on
average 5-fold higher and 2-fold higher, respectively,
than after Y. pestis exposure (Figure 2). IL-10 differential
expression was specific to the Yersinia spp. because ex-
posure to B. anthracis strains showed comparable IL-10
levels to that in unexposed control.
The HOPACH algorithm estimated the number of
clusters as five, and grouped the samples based on their
host cytokine expression profiles as follows: 1) Y. pestis
(KIM5 D27, India/P, and NYC), 2) Y. pseudotuberculosis,
3) Y. enterocolitica, 4) B. anthracis (Ames and Sterne),
and 5) Control (Figure 3). The closer the pathogen-
exposed samples are within the tree on the left, the more
similar they are. Height of the branches indicates the dis-
tance between the successive nodes in the clustering.
The method separated the B. anthracis and Yersinia
infected blood samples. In addition, the cytokine profile
of the mock-exposed control was more similar to the
pattern produced by B. anthracis exposure than to the
profile elicited by Yersinia.
Results of the hierarchical clustering when using the
Euclidean distance between samples depended on the
distance metric between clusters. The three methods for
determining the distance between clusters (complete
linkage, single linkage, and average linkage, see Materials
and Methods) all established three major clusters: 1) Y.
pestis and near neighbors, 2) B. anthracis, and c) Con-
trol. Differences between the results occurred when the
Yersinia cluster was further divided. The average linkage
Figure 2 Concentrations of 8 cytokines in human whole blood after ex vivo exposure to pathogens. The control was a mock-exposed
sample. Cytokine concentrations were determined using protein arrays. The bars represent the average of three replicate samples that each
contain 5 replicate features per cytokine assay and the lines represent the standard deviation among the three replicates.
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the three Y. pestis strains, then grouped them first with
Y. pseudotuberculosis followed by Y. enterocolitica.
Complete and single linkage methods, however, first
grouped the attenuated virulent strain of Y. pestis (India/P)
with the more virulent strain (NYC), both clinical isolates
from human plague cases, and then clustered them with
Y. pseudotuberculosis, followed by the attenuated Y. pestis
(KIM5 D27), and lastly with Y. enterocolitica. This is inter-
esting from an evolutionary perspective because it has been
proposed that Y. pestis evolved from Y. pseudotuberculosis
within the last 10,000 years, and thus these two pathogens
are more closely related [11].
When using hierarchical clustering with the correlation
distance between the samples, the final clusters were in-
dependent of the distance metric between clusters, and
agreed with the tree structure in Figure 3. The complete,single, and average linkage methods all resulted in the
following major clusters: 1) Yersinia, 2) B. anthracis, and
3). Control. Within the Yersinia cluster, Y. pestis (NYC)
was closest to Y. pestis (India/P), followed by Y. pestis
(KIM5 D27), Y. pseudotuberculosis, and Y. enterocolitica.
Discussion
The HOPACH clustering method (Figure 3) produced
five distinctly separated clusters: 1) Y. pestis (KIM5 D27,
India/P, and NYC), 2) Y. pseudotuberculosis, 3) Y. entero-
colitica, 4) B. anthracis (Ames and Sterne), and 5) Con-
trol. This result is consistent with the findings using the
correlation distance and the Euclidean distance with
average linkage. In addition, HOPACH estimated the op-
timal number of clusters as five. That is, the Yersinia
subcluster is best if it is divided into the three clusters
specified by 1) through 5) above. Y. enterocolitica forms
Figure 3 Clustering result with HOPACH using the average linkage distance between clusters is shown. The eight pathogen-exposed
samples are clustered according to the dendrogram on the left and cluster into five groups, 1) Y. pestis (KIM5, NYC, and India), 2) Y.
pseudotuberculosis, 3) Y. enterocolitica, 4) B. anthracis (Ames and Sterne), and 5) Control. Sixteen cytokines (Eotaxin, IL-10, IL-12(p40), IL-15, IL-1α, IL-
1β, IL-6, IL-8, IP-10, MCP-1, MIG, TNFα, TRAIL, sCD23, sCD95, and sICAM-1) are also reordered based on their correlations according to the
dendrogram on the top. Clusters go from root at top to leaf node for each cytokine. Clusters in between are based on their agglomerative . The
branch shows the similarity, the short the branch, the more similar. In addition, the eight rightmost proteins form a cluster that may involve
inflammation-related cascades initiated by an innate immune response to these pathogen. Colors represent units of log10 [pg/ml], in ten equally
spaced intervals increasing from white to dark red. A key showing the specific log10 values for each interval is shown in the figure.
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tis (KIM5 D27), Y. pestis (India/P), and Y. pestis (NYC)
are grouped into one cluster. Further subdivisions lead
to an overall clustering with inferior quality.
In addition to clustering the cytokine expression pro-
files across bacterial treatments, Figure 3 also groups the
cytokines themselves and clusters the proteins based on
their similarities across the pathogen exposures and reor-
ders them accordingly. Interestingly, the three pro-in-
flammatory cytokines IL-1β, TNFα, and IL-6 clustered
closely, and so did the three chemokines MCP-1, IP-10,
and IL-8. Although these 6 cytokines do not cluster as a
single group, they do cluster at a branch further away
from the leaf node, which includes IL-10 and sCD95, to
make a larger group of 8 proteins. Several of these pro-
teins are involved in inflammatory conditions, such as
IL-1beta, TNFα, IL-6, [22] and have been shown to be
upregulated in cell culture and animal model specifically
exposed to biothreat agents [23]. Increased expression of
IL-6 and TNFα clustered together in a study involving
mouse splenic CD11b + cells following sub-lethal Y.
enterocolitica infection [24]. In addition, several of the
cytokines in this cluster, namely TNF-alpha, IL1-beta,
IL-10, and MCP-1 are expressed higher in exposed whole
blood as compared to control in this study and in whole
blood exposure to LPS from several other gram negative
bacterial pathogens [19]. In addition to expression differ-
ences, the absence of detected cytokine expression can
also be helpful in discriminating pathogen exposure.The multiplex detection of 30 cytokines in this study
revealed the early phase cytokine expression profiles in
human plasma following exposures to B. anthracis
(Ames and Sterne), Y. pestis (KIM5 D27, NYC and
India/P), Y. pseudotuberculosis, and Y. enterocolitica.
The expression levels of 8 cytokines, IL-1α, IL-1β, IL-6,
IL-8, IL-10, IP-10, MCP-1, and TNFα were significantly
different from that of unexposed control (Figure 2). Al-
though the focus of our work was to show that cytokine
expression profiling can discriminate between different
pathogen exposures in a human whole blood ex vivo
model, these results also represent an initial attempt to
characterize the full cytokine response to each individual
pathogen. Our preliminary study using a single exposure
protocol at a single time post-exposure will need to be
supplemented with more thorough investigation in order
to determine the usefulness of using cytokine levels for
diagnosing pathogen exposure. However, the single time
point chosen, 4 hours, is sufficient to detect proteomic
changes and has been used in previous studies examin-
ing cytokine levels [25-27]. This time point represents a
start towards a more complete temporal study\, as has
been done with gene expression patterns for two of the
pathogens studied here [25,27]. In addition, studies that
provide expression patterns for a single cytokine using
multiple time points will also be needed to make the
results of this paper clinically useful, such as has been
done by, Cooper and coworkers, who examined IL-
12p40 and IL-12p70 levels following different growth
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pestis exposed dendritic cells [28]. The results of the
current work shows a similar expression pattern trend
to this previous work, in which, Y. pestis induces IL-
12p40 and at a substantially higher level than IL-12p70.
Our results showed that the expression levels of 3
chemokines, IL-8, MCP-1 and IP-10, were induced by
both Yersinia and B. anthracis exposures. No significant
differences were found for these cytokines between
Yersinia and B. anthracis exposures. IL-8, MCP-1 and
IP-10 are chemokines that enable the migration of
leukocytes from the blood to the site of inflammation.
IL-8 is a key chemokine regulating neutrophil recruit-
ment [29]. The essential involvement of IL-8 in acute
inflammation was demonstrated by neutralizing IL-8
with its antibody. When highly specific antibody against
IL-8 was administered in acute inflammatory reactions
induced by several stimuli including lipopolysaccharide,
neutrophil infiltration was blocked [30]. MCP-1 is
known for its ability to act as potent chemoattractant
and activator of monocytes/macrophages as well as NK
cells but not neutrophils [31,32] . IP-10 has no chemo-
tactic activity for neutrophils but attracts monocytes,
NK, and T cells to the site of infection and regulates T
cell maturation [33,34]. It was reported previously that
elevated IL-8 and MCP-1 were secreted by human epi-
thelial cells after Y. enterocolitica infection, but not IP-
10 [35,36]. Human dendritic cells, infected with B.
anthracis spores, secreted high level of IL-8 at 7.5 hours
[16]. In our study, the fold increase of IL-8 was much
greater than MCP-1 and IP-10 (Figure 2). For example,
the induction of IL-8 by Ames strain of B. anthracis
was 41 fold, while MCP-1 was 2 fold and IP-10 was 2.5
fold (Figure 2). This result may indicate that IL-8 is a
dominant chemokine in early response (4 hours expos-
ure in our study) and neutrophils are the major player
in early inflammatory response.
Here we compared cytokines induced by B. anthracis
and Yersinia exposures. Overall, Yersinia exposure
induced higher levels of IL-1α, IL-1β, IL-6, IL-10 and
TNFα than B. anthracis exposure, suggesting these cyto-
kines could be used to develop an assay for discriminat-
ing Yersinia spp. from B. anthracis exposures. The
vaccine strain (Sterne) of B. anthracis induced higher
levels of IL-1β and TNFα than the virulent strain (Ames)
(Figure 2), suggesting these cytokines can contribute to a
biomarker panel to discriminate if a particular isolate of
B. anthracis is virulent. There was also a difference in in-
duction of IL-10 between Y. pestis and near neighbors
(Figure 2), suggesting this cytokine is a candidate bio-
marker for discriminating the virulence of Yersinia spe-
cies. These data regarding IL-10 expression following
Yersinia spp. exposure are in agreement with published
literature that shows Y. enterocolitica and Y. pestis canelicit statistically different levels of IL-10 expression [37].
Differences in IL-10 induction may be due to differences
in the lcrV protein among Yersinia spp. [38]. The differ-
ent cytokine profiles induced by B. anthracis and Yersi-
nia here may be partially due to different surface
antigens on the outermost part of these pathogens and
the manner in which these bacteria were grown. Lipo-
polysaccharide (LPS), the main constituent of the outer
membrane of Gram-negative bacteria, and peptidoglycan
(PGN), the major cell wall component of Gram-positive
bacteria, have been reported to elicit markedly different
immune responses [39]. However, virulence factors, such
as B. anthracis lethal toxin and Yersinia virulence anti-
gen, LcrV, may also play important roles in differential
cytokine induction. This view is supported by numerous
reports that B. anthracis toxin and virulence factors of
Yersinia bacteria (Yops, invasin, LcrV) modulate host
cytokine responses [40-51].
While the various clustering methods resulted in
slightly different final hierarchies, all were consistent in
separating the unexposed control from the samples
exposed to B. anthracis or to the Y. pestis and near
neighbors. Agreement on this level among the various
clustering procedures lends more confidence to the over-
all results. On a more detailed level, the methods
grouped slightly differently the samples exposed to the Y.
pestis and near neighbors, which indicates that these
samples cannot be unequivocally separated based on the
current data and additional biomarkers or a larger sam-
ple set would be needed. The most advanced HOPACH
method estimated the optimal number of clusters in the
data as five, corresponding to the unexposed control,
and the four species: B. anthracis, Y. pseudotuberculosis,
Y. enterocolitica, and Y. pestis (avirulent and virulent)
(Figure 3).
Information gained from the targeted protein array
data for host response complements genomic [52-56],
and other proteomic studies [57-60] of host-pathogen
interactions. The success of the WEEM and computa-
tional method to distinguish pathogen exposure, based
on host response in this initial study, is encouraging and
suggests a number of possibilities for future studies to
refine the findings. Comparative analysis, such as the
current work, can potentially reveal the critical patho-
genic mechanism(s) and host innate immune responses
during infection as was previously shown for Y. pestis
and Y. pseudotuberculosis [61]. Opportunities include
using statistical hypothesis tests based on analysis of
variance to assess the significance of the observed differ-
ences among the host-pathogen cytokine concentration
profiles, as well as performing follow-up studies to focus
more on the Y. pestis and near neighbor cluster. In
addition, the methods can be extended to investigate
host responses to diverse pathogens in multiple host
Chromy et al. BMC Microbiology 2012, 12:79 Page 8 of 9
http://www.biomedcentral.com/1471-2180/12/79model systems to cross validate the significance of the
biomarkers to distinguish pathogen exposures.
Conclusion
Results from this study suggest that cytokine arrays
coupled with statistical clustering methods can distin-
guish exposures to pathogens, including multiple strains
of Y. pestis, Y. pseudotuberculosis, Y. enterocolitica, and
B. anthracis. These methods differentiate both near
neighbors and distant evolutionary microbes based on
host response data. The distinct cytokine profiles also
provide insight into both the host response and virulence
mechanisms of diverse pathogens. In summary,
characterization of host responses based on cytokine
profiles has translational application, potentially provid-
ing the identification of infectious diseases and leading
toward the ultimate goal of presymptomatic detection
via sentinel surveillance of pathogen exposure and ap-
propriate treatment.
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